Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw)
As interest in antibody-based drug development continues to increase, the biopharmaceutical industry has begun to focus on complex multi-specific antibodies (MsAbs) as an up-and-coming class of biologic that differ from natural monoclonal antibodies through their ability to bind to more than one typ...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | mAbs |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2022.2101183 |
| _version_ | 1828777284263215104 |
|---|---|
| author | James Sweet-Jones Maham Ahmad Andrew C.R. Martin |
| author_facet | James Sweet-Jones Maham Ahmad Andrew C.R. Martin |
| author_sort | James Sweet-Jones |
| collection | DOAJ |
| description | As interest in antibody-based drug development continues to increase, the biopharmaceutical industry has begun to focus on complex multi-specific antibodies (MsAbs) as an up-and-coming class of biologic that differ from natural monoclonal antibodies through their ability to bind to more than one type of antigen. As techniques to generate such molecules have diversified, so have their formats and the need for standard notation. Previous efforts to develop a notation language for macromolecule drugs have been insufficient, or too complex, for MsAbs. Here, we present Antibody Markup Language (AbML), a new notation language specifically for antibody formats that overcomes the limitations of existing languages and can annotate all current antibody formats, including fusions, fragments, standard antibodies and MsAbs, as well as all currently conceivable future formats. AbML V1.1 also provides explicit support for T-cell receptor domains. To assist users of this language we have also developed a tool, abYdraw, that can draw antibody schematics from AbML strings or generate an AbML string from a drawn antibody schematic. AbML has the potential to become a standardized notation for describing new MsAb formats entering clinical trials.Abbreviations: AbML: Antibody Markup Language; ADC: Antibody-drug conjugate; CAS: Chemical Abstracts Service; CH: Constant heavy; CL: Constant light; Fv: Variable fragment; HELM: Hierarchical Editing Language for Macromolecules; HSA: Human serum albumin; INN: International Nonproprietary Names; KIH: Knobs-into-holes; mAbs: Monoclonal antibodies; MsAb: Multi-specific antibody; WHO: World Health Organization; PEG: Poly-ethylene glycol; scFv: Single-chain variable fragment; SMILES: Simplified Molecular-Input Line-Entry System; VH: Variable heavy; VHH: Single-domain (Camelid) variable heavy; VL: Variable light |
| first_indexed | 2024-12-11T16:18:24Z |
| format | Article |
| id | doaj.art-c454b10e81ad4418840cb1022de065f3 |
| institution | Directory Open Access Journal |
| issn | 1942-0862 1942-0870 |
| language | English |
| last_indexed | 2024-12-11T16:18:24Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | mAbs |
| spelling | doaj.art-c454b10e81ad4418840cb1022de065f32022-12-22T00:58:54ZengTaylor & Francis GroupmAbs1942-08621942-08702022-12-0114110.1080/19420862.2022.2101183Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw)James Sweet-Jones0Maham Ahmad1Andrew C.R. Martin2Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UKInstitute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UKInstitute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UKAs interest in antibody-based drug development continues to increase, the biopharmaceutical industry has begun to focus on complex multi-specific antibodies (MsAbs) as an up-and-coming class of biologic that differ from natural monoclonal antibodies through their ability to bind to more than one type of antigen. As techniques to generate such molecules have diversified, so have their formats and the need for standard notation. Previous efforts to develop a notation language for macromolecule drugs have been insufficient, or too complex, for MsAbs. Here, we present Antibody Markup Language (AbML), a new notation language specifically for antibody formats that overcomes the limitations of existing languages and can annotate all current antibody formats, including fusions, fragments, standard antibodies and MsAbs, as well as all currently conceivable future formats. AbML V1.1 also provides explicit support for T-cell receptor domains. To assist users of this language we have also developed a tool, abYdraw, that can draw antibody schematics from AbML strings or generate an AbML string from a drawn antibody schematic. AbML has the potential to become a standardized notation for describing new MsAb formats entering clinical trials.Abbreviations: AbML: Antibody Markup Language; ADC: Antibody-drug conjugate; CAS: Chemical Abstracts Service; CH: Constant heavy; CL: Constant light; Fv: Variable fragment; HELM: Hierarchical Editing Language for Macromolecules; HSA: Human serum albumin; INN: International Nonproprietary Names; KIH: Knobs-into-holes; mAbs: Monoclonal antibodies; MsAb: Multi-specific antibody; WHO: World Health Organization; PEG: Poly-ethylene glycol; scFv: Single-chain variable fragment; SMILES: Simplified Molecular-Input Line-Entry System; VH: Variable heavy; VHH: Single-domain (Camelid) variable heavy; VL: Variable lighthttps://www.tandfonline.com/doi/10.1080/19420862.2022.2101183Antibodiesdrawing programantibody formatsmulti-specific antibodiesmarkup languageschematic figure |
| spellingShingle | James Sweet-Jones Maham Ahmad Andrew C.R. Martin Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw) mAbs Antibodies drawing program antibody formats multi-specific antibodies markup language schematic figure |
| title | Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw) |
| title_full | Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw) |
| title_fullStr | Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw) |
| title_full_unstemmed | Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw) |
| title_short | Antibody markup language (AbML) — a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw) |
| title_sort | antibody markup language abml a notation language for antibody based drug formats and software for creating and rendering abml abydraw |
| topic | Antibodies drawing program antibody formats multi-specific antibodies markup language schematic figure |
| url | https://www.tandfonline.com/doi/10.1080/19420862.2022.2101183 |
| work_keys_str_mv | AT jamessweetjones antibodymarkuplanguageabmlanotationlanguageforantibodybaseddrugformatsandsoftwareforcreatingandrenderingabmlabydraw AT mahamahmad antibodymarkuplanguageabmlanotationlanguageforantibodybaseddrugformatsandsoftwareforcreatingandrenderingabmlabydraw AT andrewcrmartin antibodymarkuplanguageabmlanotationlanguageforantibodybaseddrugformatsandsoftwareforcreatingandrenderingabmlabydraw |